Altogether, this analysis expands our knowledge of the p53-DREAM pathway and notably indicates that this pathway regulates many genes implicated in bone marrow failure syndromes, neurodevelopmental disorders and cancer, suggesting an explanation for the variety of clinical symptoms that might result from its deregulation. Here, KCNIP3 is linked to neurodevelopmental disorder.